Home › Nierkanker (niercelcarcinoom) › Texas › Dallas
Nierkanker (niercelcarcinoom) klinische studies in Dallas, TX
23 studies voor Nierkanker (niercelcarcinoom) zoeken deelnemers op locaties in en rond Dallas (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RekruterenFase 1
- NEO-811 Dallas Site, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekruterenFase 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #89, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruterenFase 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
DESTINY-PANTUMOUR04
RekruterenObservatieonderzoek
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruterenFase 1/2
- Baylor, Scott and White Research Institute, Dallas
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RekruterenFase 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruterenFase 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- en nog 2
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
RekruterenFase 2
- University of Texas Southwestern Medical Center, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruterenObservatieonderzoek
- UT Southwestern Medical Center, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
RekruterenFase 1/2
- Mary Crowley Cancer Research, Dallas
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekruterenFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
RekruterenFase 2
- University of Texas, Southwestern Medical Center, Dallas
PET/MR for Characterization of Renal Masses (RMs)
RekruterenObservatieonderzoek
- University of Texas Southwestern Medical Center, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruterenFase 1
- UT Southwestern Simmons Cancer Center, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruterenFase 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
RekruterenFase 2
- UT Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
RekruterenFase 1
- Mary Crowley Cancer Research, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RekruterenGezonde vrijwilligers welkom
- University of Texas Southwestern Medical Center, Dallas
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
RekruterenFase 1
- UT Southwestern Medical Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
RekruterenFase 2
- University of Texas Southwestern Medical Center, Dallas
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
RekruterenFase 2
- UT Southwestern Medical Center, Dallas
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RekruterenFase 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Nierkanker (niercelcarcinoom) studies in andere steden
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Pittsburgh, PA15 studies
- Philadelphia, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
- Jacksonville, FL14 studies
Andere studies in Dallas
- Borstkanker55 studies
- Niet-kleincellige longkanker52 studies
- Metastatische kanker42 studies
- Hartfalen42 studies
- Kanker (alle vormen)37 studies
- Prostaatkanker36 studies
- Colorectale kanker33 studies
- Obesitas30 studies
- Eierstokkanker28 studies
- Longkanker27 studies
- Blasenkanker27 studies
- Endometriumkanker24 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.